تداخل‌های دارویی
Cyclophosphamide + Idarubicin
شدت: شدید
Cyclophosphamide and Idarubicin: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Both drugs are cardiotoxic, and giving them together may increase the risk of cardiomyopathy and heart failure beyond that of idarubicin alone. Additive myelosuppression is also expected.
معنای این تداخل به زبان ساده
Cyclophosphamide and Idarubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Cyclophosphamide belongs to Oncology; Idarubicin belongs to Oncology.
چرا رخ می‌دهد
Additive cardiotoxicity, possibly via increased formation of toxic anthracycline metabolites in myocardium, plus additive myelosuppression.
اقدام لازم
Assess left ventricular function before and during treatment, and keep cumulative anthracycline dose within recommended limits. Monitor blood counts and consider cardioprotective measures in high-risk patients.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Cyclophosphamide و Idarubicin، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Cyclophosphamide
تداخلات دیگر Idarubicin
پرسش‌های متداول
Can I take Cyclophosphamide with Idarubicin?
MediHelp rates the interaction as major. Cyclophosphamide and Idarubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs are cardiotoxic, and giving them together may increase the risk of cardiomyopathy and heart failure beyond that of idarubicin alone. Additive myelosuppression is also expected.
How serious is the interaction between Cyclophosphamide and Idarubicin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Assess left ventricular function before and during treatment, and keep cumulative anthracycline dose within recommended limits. Monitor blood counts and consider cardioprotective measures in high-risk patients.
What other medicines interact with Cyclophosphamide?
MediHelp also lists interactions of Cyclophosphamide with, for example, Adenovirus types 4 and 7 live, Belatacept, Bendamustine. The full list is on the Cyclophosphamide page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
